Shaanxi Meibang Pharmaceutical Group Co Ltd605033
▲ ポジティブ資本関連度
Board approved an 80 million yuan capital increase into its wholly-owned biotech subsidiary and the establishment of a wholly-owned Hong Kong subsidiary.
銘柄への影響 1
その他
Shaanxi Meibang Pharmaceutical Group Co Ltd